Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 6, 2007, Pages 1159-1167

  Makkat, Smitha ^a   Luypaert, R ^a   Sourbron, S ^a   Stadnik, T ^a   De Mey, J ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Blood flow; Breast tumors; Deconvolution; Dynamic MRI; Model independent quantification

Indexed keywords

ADULT; ARTICLE; BREAST TUMOR; CLINICAL ARTICLE; COHORT ANALYSIS; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERFUSION; PERMEABILITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR BLOOD FLOW; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC;

EID: 34249903864     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20937     Document Type: Article

References (40)

1. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992:3:65-71.
2. Degani H, Chetrit-Dadiani M, Bogin L, Furman-Haran E. Magnetic resonance imaging of tumor vasculature. Thromb Haemost 2003:89:25-33.
3. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994:193:777-781.
4. Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 1999;6:387-397.
5. Boetes C, Mus RDM, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995;197:743-747.
6. Piccoli CW. The specificity of contrast-enhanced breast MR imaging. Magn Reson Imaging Clin N Am 1994:2:557-571.
7. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.
8. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;16:407-422.
9. Makkat S, Sourbron S, Dujardin M, Van Schuerbeek P, Luypaert R, Stadnik T. Deconvolution-based contrast enhanced MR imaging of breast tumors for perfusion quantification: a feasibility study. In: Proceedings of the 13th Annual Meeting of ISMRM, Miami Beach, FL. USA, 2005 (Abstract 743).
10. Sourbron S, Dujardin M, Luypaert R, et al. Quantification of cerebral tumor perfusion and permeability witha deconvolution analysis of T1-weighted bolus tracking data. In: Proceedings of the 21st Annual Meeting of ESMRMB, Copenhagen, Denmark, 2004 (Abstract 188).
11. Dujardin M, Sourbron S, Luypaert R, Verbeelen D, Stadnik T. Quantification of renal perfusion and function on a voxel-by-voxel basis: a feasibility study. Magn Reson Med 2005;54:841-849.
12. Jerosch-Herold M, Swingen C, Seethamraju RT. Myocardial blood flow quantification with MRI by model-independent deconvolution. Med Phys 2002:29:886-897.
13. Ivancevic MK, Zimine I, Lazeyras F, Foxall D, Vallee JP. FAST sequences optimization for contrast media pharmacokinetic quantification in tissue. J Magn Reson Imaging 2001;14:771-778.
14. Fritz-Hansen T, Rostrup E, Henrik B, et al. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996;36:225-231.
15. Kostler H, Ritter C, Lipp M, Beer M, Hahn D, Sandstede J. Prebolus quantitative MR heart perfusion imaging. Magn Reson Med 2004;52:296-299.
16. Jerosch-Herold M, Hu X, Murthy NS, Rickers C, Stillman AE. Magnetic resonance imaging of myocardial contrast enhancement with MS-325 and its relation to myocardial blood flow and the perfusion reserve. J Magn Reson Imaging 2003;18:544-554.
17. Makkat S, Sourbron S, Luypaert R, et al. Characterization of breast tumors with a deconvolution analysis of bolus tracking data: initial results. In: Proceedings of the 22nd Annual Meeting of ESMRMB, Basel, Switzerland, 2005 (Abstract 516).
18. Calamante F, Gadian DG, Connelly A. Quantification of bolus-tracking MRI: Improved characterization of the tissue residue function using Tikhonov regularization. Magn Reson Med 2003;50:1237-1247.
19. Sourbron S, Luypaert R, Van Schuerbeek P, Dujardin M, Stadnik T, Osteaux M. Deconvolution of dynamic contrast-enhanced MRI data by linear inversion: choice of the regularization parameter. Magn Reson Med 2004;52:209-213.
20. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000:21:462-470.
21. Sourbron S, Makkat S, Dujardin M, Luypaert S, Van Schuerbeek P, Stadnik T. The inflow effect in dynamic studies with the prepared FLASH sequence: theoretical study and validation in vivo. In: Proceedings of the 22nd Annual Meeting of ESMRMB, Basel, Switzerland, 2005 (Abstract 518).
22. Peeters F, Annet L, Hermoye L, Van Beers BE. Inflow correction of hepatic perfusion measurements using T1-weighted, fast gradient-echo, contrast-enhanced MRI. Magn Reson Med 2004:51:710-717.
23. Ivancevic MK, Zimine I, Montet X, et al. Inflow effect correction in fast gradient-echo perfusion imaging. Magn Reson Med 2003;50:885-891.
24. Zheng J, Venkatesan R, Haacke EM, Cavagna FM, Finn PJ, Li D. Accuracy of T1 measurements at high temporal resolution: feasibility of dynamic measurement of blood T1 after contrast administration. J Magn Reson Imaging 1999;10:576-581.
25. Makkat S, Sourbron S, Dewilde V, et al. Characterisation of breast tumors with a model-independent analysis of bolus-tracking MRI. In: Proceedings of the 14th Annual Meeting of ISMRM, Seattle, WA, USA, 2006 (Abstract 1797).
26. Lanfranchi PA, Somers VK. Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol 2002;283:815-826.
27. Weinstein D, Strano S, Cohen P, Fields S, Gomori JM, Degani H. Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging - pilot study. Radiology 1999;210:233-240.
28. Vaupel P, Hockel M. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. Int J Oncol 2000;17:869-879.
29. Furman-Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer 2005:104:708-718.
30. Brix G, Kiessling F, Lucht R, et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004;52:420-429.
31. Daldrup HE, Shames DM, Husseini W, Wendland MF, Okuhata Y, Brasch RC. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries. Magn Reson Med 1998;40:537-543.
32. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002;179:783-789.
33. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging-initial results. Radiology 2002:223:558-565.
34. Vaupel P. Physiological properties of malignant tumours. NMR Biomed 1992;5:220-225.
35. Sourbron S, Dujardin M, Makkat S, Luypaert R, Van Schuerbeek P, Stadnik T. The residue function of the two-compartment model with a single input: theory and initial results. In: Proceedings of the 22nd Annual Meeting of ESMRMB, Basel, Switzerland, 2005 (Abstract 517).
36. Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging 2004;20:353-365.
37. Risse F, Fink C, Kauczor H, Semmler W. Dual bolus approach for quantitative measurement of pulmonary perfusion by contrast enhanced MRI. In: Proceedings of the 22nd Annual Meeting of ESMRMB, Basel, Switzerland, 2005 (Abstract 471).
38. Jerosch-Herold M, Hu X, Murthy NS, Seethamraju RT. Time delay for arrival of MR contrast agent in collateral-dependent myocardium. IEEE Trans Med Imaging 2004:23:881-890.
39. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000:44;466-473.
40. Su MY, Wang Z, Carpenter PM, Lao X, Muhler A, Nalcioglu O. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. J Magn Reson Imaging 1999;9:177-186.